Improved glycemic control In adults with type 2 diabetes, weekly semaglutide lowered long-term blood sugar (HbA1c) by about 1.5 points, while placebo barely moved (The Lancet Diabetes & Endocrinology, 2017)
Author contributions DU: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Software, Validation, Visualization, Writing original draft, Writing review & editing
Consuming calorie-dense, nutrient-poor meals can diminish the weight management benefits of GLP-1 drugs, even though the medication continues to function at a molecular level
The vascular characteristics of melasma
"While I think it makes sense to study this for specific applications, there is really no evidence to date indicating any meaningful benefit from routine use